ZACHARY BROOKS: Open Payments
NPI 1770087322 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 37 payments from 18 companies in 2025. Trend: 2023 $795 · 2024 $846 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $149 |
| Intra-Sana Laboratories | 1 | $139 |
| Madrigal Pharmaceuticals | 3 | $77 |
| NeurAxis, Inc. | 1 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| Janssen Biotech, Inc. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 1 | $52 |
| QOL Medical, LLC | 2 | $48 |
| PFIZER INC. | 2 | $41 |
| Ardelyx, Inc. | 2 | $40 |
Products named: RELTONE 200 MG, REZDIFFRA, TREMFYA, ENTYVIO, DUPIXENT, Sucraid, XELJANZ, RINVOQ.
Industry payments across FL — which companies pay providers there.
